The FDA’s new draft guidance on Bayesian methodology signals a shift toward more flexible, data-driven clinical trial designs, enabling sponsors to use prior data and adaptive approaches to improve ...
Cure models represent an important extension of conventional survival analysis, allowing researchers to distinguish between individuals who remain susceptible to an event and those who are effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback